Milestone Pharmaceuticals Inc. (MIST) Form S-3 — May 13, 2026
Milestone Pharmaceuticals Inc. has filed a shelf registration statement (Form S-3) with the SEC, allowing the company to offer up to $300 million in various securities, including common shares, preferred shares, debt securities, and warrants. This provides the company with the flexibility to raise capital as needed in the future. The company has also entered into a Controlled Equity OfferingSM Sales Agreement with Cantor Fitzgerald & Co., which allows for the sale of up to $100 million in common shares through an 'at the market' offering.
Key figures
- Dilution Per Share
- 1.13
- Total Shelf Capacity
- 300000000
- Common Shares Outstanding
- 117794417
- Net Tangible Book Value Per Share
- 0.30
- As Adjusted Net Tangible Book Value Per Share
- 0.77
- Maximum Offering Price Common Shares
- 100000000
Price after filing
Close on the filing date to close N calendar days later (from $1.72). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.